Arix Bioscience plc
( the "Company")
05 May 2023
Total Voting Rights
The Company confirms that its total issued share capital at the close of business on 4 May 2023 comprised 135,609,653 Ordinary Shares of 0.001 pence each fully paid. This figure includes 6,220,145 Ordinary Shares which are held in Treasury, leaving a balance of 129,389,508 Ordinary Shares with each share carrying the right to one vote.
The above figure of 129,389,508 may be used by shareholders for the calculations by which they will determine if they are required to notify their major interest in, or a change to their major interest in, Arix Bioscience plc under the Disclosure Guidance and Transparency Rules.
For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486